TFF Group (OTCMKTS:FRFTF) Sees Significant Drop in Short Interest

TFF Group (OTCMKTS:FRFTF) was the recipient of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 3,188 shares, a decline of 73.7% from the June 15th total of 12,115 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

TFF Group Price Performance

TFF Group stock remained flat at C$17.50 during mid-day trading on Tuesday. The company’s 50 day moving average is C$17.50 and its two-hundred day moving average is C$18.97. TFF Group has a 1-year low of C$17.50 and a 1-year high of C$20.14.

TFF Group Company Profile

TFF Group (OTCMKTS:FRFTF) is a clinical-stage specialty pharmaceutical company developing and commercializing medicines based on its proprietary thin-film drug delivery platform. The company’s core technology transforms active pharmaceutical ingredients into solid films that dissolve rapidly in the oral cavity or adhere to mucosal surfaces, enabling precise dosing without water, potential improvements in bioavailability and the opportunity to create novel dosage forms. TFF Group’s platform supports a broad range of molecules, from small-molecule drugs and peptides to vaccines and biologics.

Headquartered in Kansas City, Missouri, with research and manufacturing facilities in Europe, TFF Group applies its thin-film technology across multiple therapeutic areas, including central nervous system disorders, hormone replacement therapy, respiratory diseases and vaccines.